Prof Dr.Gilles PERNOD – Cardiovascular Oncology – Best Researcher Award

Published on 08/01/202428/02/2024 by Oncology

Prof Dr.Gilles PERNOD - Cardiovascular Oncology - Best Researcher Award

CHU Grenoble-Alpes - France

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS

Gilles PERNOD embarked on his academic journey with a strong foundation, earning his A-levels in Mathematics in 1979. His dedication and early academic achievements laid the groundwork for a distinguished career in the field of medicine.

PROFESSIONAL ENDEAVORS

Gilles PERNOD's professional journey officially began with the completion of his degree in Medicine in 1985, marking the commencement of his commitment to the medical field.Driven by a thirst for knowledge, PERNOD furthered his academic pursuits, achieving a Doctorate in Medicine in 1991. This academic milestone showcased his dedication to advancing medical understanding. PERNOD's expertise expanded into the realm of Haematology in 1998 when he assumed the role of Assistant Professor, contributing significantly to the medical education landscape.Recognizing his exemplary contributions, PERNOD attained the prestigious title of Professor of University in Vascular Medicine in 2007, a testament to his expertise and leadership in the field.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR ONCOLOGY

Throughout his career, PERNOD has been instrumental in advancing vascular medicine and haematology. As the Head of the Vascular Medicine Unit since 2018 at CHU Grenoble-Alpes, he continues to lead groundbreaking research initiatives. PERNOD's leadership of the ThEMAS TIMC IMAGUMR CNRS 5525 research group highlights his commitment to collaborative and innovative research, contributing to the collective understanding of thrombo-embolic diseases.His involvement in the INNOVTE Network emphasizes PERNOD's dedication to enhancing thrombo-embolic disease diagnostics and clinical research on an international scale.

IMPACT AND INFLUENCE

Gilles PERNOD's influence extends globally through active participation in international societies and professional associations. Membership in the International Society of Thrombosis and Haemostasis showcases his commitment to staying at the forefront of advancements in his field.

ACADEMIC CITES

As a Professor of University, PERNOD's academic contributions are evidenced by his Qualification to Direct Student Research in 2004. This recognition underscores the impact of his research and mentorship on the next generation of medical professionals.

LEGACY AND FUTURE CONTRIBUTIONS

Gilles PERNOD's legacy is marked by his significant contributions to vascular medicine, cardiovascular oncology and haematology. His commitment to ongoing research, coupled with leadership roles, positions him to continue shaping the future landscape of these fields. His influence on perioperative hemostasis and commitment to medical education underscore his dedication to advancing medical knowledge.

NOTABLE PUBLICATIONS

Management of venous thromboembolic disease in patients with malignant brain tumours .2024

Update About the Management of Low-Density Lipoprotein Cholesterol and Hypertriglyceridemia in Lower Extremity Peripheral Artery Disease Patients: Consensus of the French Society of Vascular Medicine and the French Society for Vascular and Endovascular Surgery.2023

Mr.Eric Naab Manson – Medical Physics – Best Scholar Award

Published on 05/01/202428/02/2024 by Oncology

Mr.Eric Naab Manson - Medical Physics - Best Scholar Award

University for Development Studies - Ghana

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Commencing with the Senior Secondary School Certificate Examination at Kanton Senior Secondary School from 2001 to 2003, Eric laid the foundation for his academic journey.

PROFESSIONAL ENDEAVORS:

Eric's career spans diverse roles, from being a Physics Tutor to an Assistant Lecturer, showcasing his commitment to both education and the advancement of medical physics.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICAL PHYSICS

Dedicated to medical imaging and cancer research, Eric actively contributes to advancing diagnostics and treatments. His engagement with research groups emphasizes collaboration for groundbreaking discoveries.

IMPACT AND INFLUENCE:

Through teaching roles and ongoing research, Eric has the potential to influence academic and practical aspects of medical physics, leaving a lasting impact on students and the field.

ACADEMIC CITES:

Eric's pursuit of a Ph.D. in Medical Physics at the University of Ghana suggests an ongoing and impactful academic journey.

LEGACY AND FUTURE CONTRIBUTIONS:

Eric's legacy lies in his dedication to medical physics education and research. As he continues his Ph.D., his future contributions are expected to enrich the field, with a collaborative and exploratory approach indicating sustained impact.

NOTABLE PUBLICATIONS

Fighting breast cancer in low-and-middle-income countries – What must we do to get every woman screened on regular basis?2023

Evaluation of the impact of magnetic field homogeneity on image quality in magnetic resonance imaging: a baseline quantitative study at 1.5 T. 2023

Dr. Siim Pauklin – Targeted Cancer Therapy – Best Researcher Award

Published on 05/01/202428/02/2024 by Oncology

Dr. Siim Pauklin - Targeted Cancer Therapy - Best Researcher Award

University of Oxford - United Kingdom

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Siim Pauklin embarked on his academic journey with a Bachelor's degree in Molecular and Cell Biology from the University of Tartu in Estonia, earning the distinction of Diploma Cum Laude in 2004. He further pursued his academic interests with a Master's degree in Molecular and Cell Biology at the same institution, completing it with distinction in 2005. His early academic pursuits showcased exceptional dedication and achievement in the field.

PROFESSIONAL ENDEAVORS:

Following his Master's degree, Siim Pauklin expanded his academic horizons with a Ph.D. in Biochemistry and Molecular Biology at University College London / CRUK London Research Institute from September 2005 to October 2009. His Ph.D. research, titled "Regulation of Activation Induced Deaminase (AID)," not only earned him the prestigious Pontecorvo prize for the best thesis in CRUK but also led to groundbreaking discoveries in the regulation of AID expression by hormones and its role in immune responses, autoimmune diseases, and tumorigenesis.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

Siim Pauklin's research has been instrumental in advancing our understanding of stem cell biology and cancer research, particularly in the molecular mechanisms regulating cancer stem cell formation. His work on the TGFß/Activin/Nodal-SMAD2/3 signaling pathway in pancreatic ductal adenocarcinomas and cancer stem cells has paved the way for insights into chemoresistance, metastatic capacity, and the 3D chromatin architecture of pancreatic cancer.

IMPACT AND INFLUENCE:

Siim Pauklin's impact in the field is evident from his career trajectory, securing prestigious fellowships, awards, and recognition for his significant contributions. His leadership as a Principal Investigator and CRUK Career Development Fellow at the University of Oxford underscores his influence in the scientific community.

LEGACY AND FUTURE CONTRIBUTIONS:

Siim Pauklin's research focus on Targeted cancer therapy and pancreatic cancer. As he continues to lead his research group at the University of Oxford, his commitment to uncovering early detection methods and advancing therapeutic strategies for cancer stem cells promises a lasting impact on the field. His future contributions are anticipated to further shape our understanding of cancer biology and contribute to the development of novel cancer therapies.

NOTABLE PUBLICATIONS

BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma. 2023

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics. 2023

Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation.2023

Dr.Antonio Prinzi – Endocrine Oncology – Best Researcher Award

Published on 04/01/202428/02/2024 by Oncology

Dr.Antonio Prinzi - Endocrine Oncology - Best Researcher Award

University of Catania - Italy

AUTHOR PROFILE

ORCID

EARLY ACADEMIC PURSUITS:

Antonio Prinzi, MD, began his academic journey at the University of Palermo, earning his Degree in Medicine and Surgery in July 2020 with the exceptional grade of 110/110 cum laude. His early academic pursuits laid the foundation for his subsequent achievements and contributions in the field of endocrinology and metabolism.

PROFESSIONAL ENDEAVORS:

Following his medical degree, Dr. Prinzi registered with the Order of Doctors of Palermo in August 2020. He then undertook a Post-graduate Fellowship in Endocrinology and Metabolism Diseases at the University of Catania, a nationally renowned specialist Medical Center (ARNAS) Garibaldi, starting in January 2021 and continuing to the present. Additionally, he gained valuable international experience during his Fellowship and research at Erasmus MC: University Medical Center in Rotterdam from December 2022 to June 2023.

CONTRIBUTIONS AND RESEARCH FOCUS ON ENDOCRINE ONCOLOGY

Dr. Prinzi's research focus is evident in his scientific publications. Notably, he contributed to a study on circulating Irisin levels as a marker of osteosarcopenic-obesity in Cushing's disease, published in Diabetes Metab Syndr Obes in May 2020. Another publication in Endocr Pract in November 2023 explores the lymph node ratio as a predictive factor of persistent/recurrent disease in patients with medullary thyroid cancer.

IMPACT AND INFLUENCE:

His impact is evident in his role as a Post-graduate Fellow at the University of Catania, where he actively contributes to the field of endocrine oncology. The international experience gained in Rotterdam further enhances his influence on a global scale, fostering collaboration and knowledge exchange.

ACADEMIC CITES:

Dr. Prinzi's work has been cited in reputable journals, showcasing the recognition and relevance of his research contributions. The citations demonstrate the impact of his studies on the scientific community.

LEGACY:

As a young and accomplished medical professional, Dr. Prinzi is building a legacy marked by academic excellence, research contributions, and a commitment to advancing endocrinological knowledge. His early accomplishments and international experiences contribute to the foundation of his lasting legacy in the medical field.

FUTURE CONTRIBUTIONS:

Looking forward, Dr. Prinzi's future contributions are anticipated to further enrich the field of endocrinology. His dedication to research, international exposure, and clinical expertise position him for continued impact in understanding and treating endocrine and metabolic diseases.

Notable Publication

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease. 2020

Aya H. Soliman – Tumor Immunology – Best Researcher Award

Published on 03/01/202428/02/2024 by Oncology

Ms.Aya H. Soliman - Tumor Immunology - Best Researcher Award

German University in Cairo - Egypt

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Aya H. Soliman's academic journey commenced with a fervent pursuit of knowledge. Her early years were marked by a dedication to learning, demonstrating an insatiable curiosity and a penchant for academic excellence. Whether it be notable achievements, academic milestones, or early influences, this period laid the foundation for her future endeavors.

PROFESSIONAL ENDEAVORS:

Embarking on a path of professional growth, Soliman transitioned seamlessly from academia to the professional realm. Her career trajectory reflects a commitment to applying theoretical knowledge to real-world challenges. A closer examination of her professional undertakings unveils a strategic and purposeful approach to making significant contributions in her chosen field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Soliman's contributions to her field are nothing short of groundbreaking. Her research focus is characterized by a meticulous exploration of pertinent issues, coupled with innovative methodologies. By delving into specific themes, she has enriched the academic landscape with fresh perspectives and novel insights, leaving an indelible mark on her area of expertise.

IMPACT AND INFLUENCE:

The impact of Soliman's work extends far beyond the confines of academia. Her research and professional activities have influenced not only fellow scholars but also practitioners in the field. By contributing to the advancement of knowledge, she has played a pivotal role in shaping industry practices and policies, showcasing a far-reaching influence.

ACADEMIC CITES:

A quantitative measure of Soliman's academic influence lies in the citation of her work. The number of times her research has been referenced underscores its significance within scholarly discourse. Her contributions have become integral to the academic canon, with citations serving as a testament to the enduring relevance of her ideas.

FUTURE CONTRIBUTIONS:

Looking ahead, Soliman's future contributions hold promise for continued innovation and advancement. Anticipating the evolving landscape of her field, she remains poised to address emerging challenges and contribute novel solutions. The trajectory of her future contributions is eagerly awaited, promising to shape the direction of academic and professional discourse.

Notable Publications

Maria A. Perez Herrero – Perioperative Management in Oncological Surgery – Best Researcher Award

Published on 02/01/202428/02/2024 by Oncology

Dr. Maria A. Perez Herrero's - Perioperative management in oncological surgery - Best Researcher Award

Hospital Clinico Universitario de Valladolid - Spain

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Maria A. Perez Herrero commenced her academic journey with a notable achievement, obtaining her Licenciatura en Medicina y Cirugía from the Faculty of Medicine, Valladolid, with a Grado de licenciatura: SOBRESALIENTE in June 1991. This early success set the foundation for her subsequent academic and professional endeavors.

PROFESSIONAL ENDEAVORS:

Dr. Perez Herrero's commitment to medical excellence is evident in her pursuit of specialized training. Following her initial academic success, she engaged in Cursos monográficos de Doctorado en Farmacología from September 1994 to June 1996. Her dedication culminated in the completion of her Tesis Doctoral, "Alergias en la Práctica Clínica Anestesiológica," earning her the distinction of APTO CUM LAUDE in September 1997.

CONTRIBUTIONS AND RESEARCH FOCUS ON PERIOPERATIVE MANAGEMENT IN ONCOLOGICAL SURGERY

Dr. Perez Herrero made significant contributions to her field, as demonstrated by her Lectura de la Tesis Doctoral and subsequent roles as Médico Especialista en Anestesiología y Reanimación. Her engagement in Guardias en el Servicio de Urgencias and Guardias en los Servicios de Anestesia y Reanimación reflects her dedication to both emergency care and specialized anesthesia services.

IMPACT AND INFLUENCE:

Dr. Perez Herrero's impact extends beyond clinical settings. Her involvement as Profesor Colaborador Honorífico and collaborations with various departments at the Universidad de Valladolid showcase her influence in academia. Additionally, her contributions to the Real Academia de Medicina y Cirugía de Valladolid underscore her standing in the medical community.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Maria A. Perez Herrero's legacy is marked by a rich tapestry of academic achievements, professional roles, and contributions to medical education. As a Profesor Colaborador Honorífico, her influence continues, shaping the education and training of future medical professionals. Her commitment to academia and clinical excellence positions her as a role model for aspiring healthcare practitioners.

NOTABLE PUBLICATIONS

Serratus-intercostal interfascial plane block: alternative analgesia for open nephrectomy?2018

Assoc Prof Dr.BOU KHALIL Rami – Pharmaco – Oncology – Best Researcher Award

Published on 30/12/202328/02/2024 by Oncology

Assoc Prof Dr.BOU KHALIL Rami - Pharmaco - Oncology - Best Researcher Award

Hotel Dieu de France / Saint-Joseph University - Lebanon

AUTHOR PROFILE

Scopus

Google Scholar

Orchid

EARLY ACADEMIC PURSUITS:

Dr. Bou Khalil began his academic journey in the field of medicine at Saint-Joseph University, Lebanon, where he completed his medical doctorate in 2006. His early academic pursuits laid the foundation for his subsequent specialization in psychiatry.

PROFESSIONAL ENDEAVORS:

Dr. Bou Khalil has amassed a wealth of clinical experience throughout his distinguished career. Notably, he has served as the Head of the Psychiatry Department at Hotel-Dieu de France in Beirut since March 2023. His clinical practice spans various settings, including private clinics, psychiatric hospitals, and addiction treatment centers. Dr. Bou Khalil has demonstrated his commitment to mental health by providing comprehensive care to patients of all ages and managing diverse mental disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

With a strong emphasis on research, Dr. Bou Khalil earned his Ph.D. from Montpellier University, France, focusing on eating disorders, psychological trauma and pharmaco-oncology. His extensive research portfolio includes investigations into topics such as the use of psychotropic drugs in oncology patients, the efficacy of Mifepristone in treating anorexia nervosa models, and the metabolic syndrome in Lebanese patients with schizophrenia. These contributions underscore his dedication to advancing knowledge in the field of psychiatry.

IMPACT AND INFLUENCE:

Dr. Bou Khalil's influence extends beyond clinical practice and research. He has played a pivotal role in various institutions, including serving as a Consultant Psychiatrist for patients with addiction at SIDC, Beirut, and contributing as a Mental Health Supervisor for the program supporting Syrian refugees. His impact is evident in his roles as a member of the scientific committee for exemption from official exams in the Lebanese Ministry of Education and as a member of the scientific committee of psychiatry in the Ministry of Public Health.

ACADEMIC CITES:

Dr. Bou Khalil's academic journey has been marked by significant achievements. He holds the position of Associate Professor of Psychiatry at Saint-Joseph University, Beirut, since December 2023. His academic contributions also include serving as an Assistant Professor and Lecturer at the university's departments of psychiatry, psychology, nursing, and the faculty of medicine. His commitment to medical education is further highlighted by obtaining a Master's degree in medical education techniques.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Bou Khalil's legacy is shaped by his multifaceted contributions to clinical practice, research, and education. His extensive involvement with organizations like the Jesuit Refugee Service and Doctors Without Borders showcases his commitment to global mental health. As an academician, clinician, and researcher, his future contributions are anticipated to continue shaping the landscape of psychiatry and mental health care in Lebanon and beyond.

NOTABLE PUBLICATION

Clinical Correlates of Measured and Predicted Resting Energy Expenditure in Patients with Anorexia Nervosa: A Retrospective Cohort Study. Nutrients.

Neutrophil-to-lymphocyte ratio (NLR) variations in relationship with childhood maltreatment in patients with anorexia nervosa: a retrospective cohort study

The impact of lockdown and other stressors during the COVID-19 pandemic on depression and anxiety in a Lebanese opportunistic sample: an online cross-sectional survey

Mr.Christopher Olowosoke – Targeted Cancer Therapy – Best Researcher Award

Published on 29/12/202328/02/2024 by Oncology

Mr.Christopher Olowosoke - Targeted Cancer Therapy - Best Researcher Award

Federal University of Technology Akure - Nigeria

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Christopher Busayo Olowosoke embarked on his academic journey with a focus on biotechnology. His dedication to academic excellence was evident during his West African Senior School Certificate Examination at Isefun Community Senior Secondary School, Lagos State, Nigeria, where he achieved a grade of Distinction in the Science stream. This early success set the stage for his future pursuits in the field of biotechnology and information technology.

PROFESSIONAL ENDEAVORS

With a passion for biotechnology and an interest in the chemistry of natural products and pharmacology, Christopher pursued his first degree at the Federal University of Technology, Akure, Ondo State, Nigeria. Graduating with an outstanding grade of 4.73/5.00 in Biotechnology in 2020, he showcased his commitment to academic excellence. His undergraduate thesis, "Identification of pungency-associated genes in some indigenous Nigerian hot pepper varieties," demonstrated his engagement with cutting-edge research.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

As a Student Research Assistant at the Federal University of Technology, Akure, Christopher actively contributed to research in the Departments of Biochemistry, Biotechnology, and Microbiology from 2017 to 2021. His involvement in in vivo, in vitro, and in silico procedures for diabetes and targeted cancer therapy underscored his commitment to addressing metabolic and cellular proliferation dysregulation, aligning with Sustainable Development Goal 3 (SDG 3). Additionally, his work on the phyto-treatment of diabetes using Andrographic paniculata showcased his dedication to innovative therapeutic approaches.

IMPACT AND INFLUENCE

Christopher's impact extended beyond the laboratory. As a Laboratory Research Assistant at Chrisland University Biotechnology Department from 2022 to the present, he played a pivotal role in organizing practical sessions and providing training in bioinformatics and molecular biology for undergraduates. His leadership as the Founder of B.Khrease Academic Consult since 2018 highlights his commitment to facilitating student projects, mentorship, and collaboration with academic experts.

ACADEMIC CITES

Christopher's research contributions are recognized through his publications. His paper titled "Multiregulator of EZH2-PPARs Therapeutic Targets" was published in Applied Biochemistry and Biotechnology in 2023. This publication addresses critical aspects of pancreatic insulin production and cancer dysregulation. The link to his full publication list on ResearchGate (https://www.researchgate.net/profile/Christopher-Olowosoke/research) reflects his ongoing scholarly pursuits.

LEGACY AND FUTURE CONTRIBUTIONS

Christopher's legacy includes leadership roles, such as being the Founder of B.Khrease Academic Consult and serving as the Promotional and Development Committee Head at the Institute of Bioinformatics and Molecular Therapeutic (IBMT) since 2021. His active participation in conferences, workshops, and professional webinars, as well as affiliations with prestigious societies, showcases his commitment to staying at the forefront of biotechnological advancements.

AWARDS/GRANT

Christopher's achievements are acknowledged through various awards and grants, including being a beneficiary of the American Society for Nutrition Early Career Professional Mentoring Program in 2023 and securing the second position in the Peeref International Best Poster Presentation in the same year. His involvement in securing the TETFUND Grant Award for the Biotechnology Department in 2022 and the UNESCO-ICB Scholarship in 2020 further demonstrates his capacity to contribute significantly to his field.

NOTABLE PUBLICATION

Multi-regulator of EZH2-PPARs Therapeutic Targets: A Hallmark for Prospective Restoration of Pancreatic Insulin Production and Cancer Dysregulation.

Prof. Yung-Feng Yen | Changes in metabolic syndrome and cancer | Best Researcher Award – Award Winner 2023

Published on 09/12/202328/02/2024 by Oncology

Yung-Feng Yen - Changes in metabolic syndrome and cancer - Best Researcher Award

Taipei City Hospital - Taiwan

Author Profile

Orcid
Researchgate

Absolutely! Recognizing Prof. Yung-Feng Yen's achievement in receiving the Best Researcher Award in the International Research Awards on Oncology and Cancer Research highlights the significance of their contributions to the field. The acknowledgment underscores their dedication, expertise, and valuable efforts in advancing our understanding of oncology and cancer research.

Prof. Yung-Feng Yen's work not only contributes to expanding the body of knowledge in the field but also has the potential to positively impact patient outcomes. Their commitment to excellence in research is commendable, and such recognition serves as a testament to the importance of their work in the broader scientific and medical community.

Once again, congratulations to Prof. Yung-Feng Yen on this remarkable achievement!

EARLY ACADEMIC PURSUITS

Yung-Feng Yen embarked on his academic journey with a solid foundation, earning a Medical Doctor Degree from Taipei Medical University of Medicine in 1999. Subsequently, he pursued a Master's in Epidemiology and later a PhD in Epidemiology at the Institute of Public Health, National Yang Ming Chiao Tung University, Taipei Taiwan, under the guidance of notable advisors such as Prof. Chung-Yeh Deng and Prof. Pesus Chou.

PROFESSIONAL ENDEAVORS

Dr. Yen's professional career has been marked by significant contributions in the field of Changes in metabolic syndrome and cancer,epidemiology and healthcare management. Starting as a Resident and Chief Resident at Taipei Veteran General Hospital, he later served as the Director of Infectious Disease Division at Taipei City Hospital, Yangming Branch. His dedication and expertise led to his appointment as an Attending Physician of Infectious Disease Division and eventually as a Professor in the Department of Health Care Management at the National Taipei University of Nursing and Health Sciences.

CONTRIBUTIONS AND RESEARCH FOCUS ON CHANGES IN METABOLIC SYNDROME AND CANCER

Dr. Yen has made substantial contributions to the field, particularly in infectious disease epidemiology. His research focuses on the Epidemiology of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV), Tuberculosis prevention and control, and Nosocomial infection control.

SHORT COURSES ATTENDED

His commitment to academic growth is evident in the short courses he attended, including a Research Fellowship in Public Health at UCLA School of Public Health (2019-2020) under the mentorship of Dr. Donald E. Morisky, and a Research Fellowship in Infectious Disease Epidemiology at the University of California San Diego (2010-2011) guided by Dr. Richard S. Garfein.

IMPACT AND INFLUENCE

Yen's impact is underscored by numerous accolades, including Best Paper Awards from prestigious institutions such as the Taiwan AIDS Society and the Taiwan Academy of Hospice Palliative Medicine. His work has not only contributed to academic recognition but has also influenced the practices and understanding of infectious diseases in Taiwan.

ACADEMIC CITES

His academic prowess is reflected in the number of citations his work has garnered, establishing him as a respected authority in the field of epidemiology and infectious diseases.

EXPERIENCE

With extensive experience as an Associate Professor at the Institute of Public Health, National Yang-Ming University, and various roles at Taipei City Hospital, Dr. Yen brings a wealth of knowledge to his current position as a Professor in the Department of Health Care Management.

LEGACY AND FUTURE CONTRIBUTIONS

Yen's legacy is characterized by a commitment to excellence in research, teaching, and healthcare management. His future contributions are anticipated to further enrich the understanding of infectious diseases, shaping the next generation of healthcare professionals and researchers.

In summary, Yung-Feng Yen's journey from early academic pursuits to his current position as a Professor showcases a remarkable career marked by academic achievements, professional excellence, impactful research, and a commitment to advancing healthcare knowledge and practice.

Key Contributions and Research:

In 2012, Dr. Yen presented his research on HIV infection control among injection drug users in Taiwan at the 1st International Congress of Gynaecology and Obstetrics in Guangzhou, China. This oral presentation highlighted his commitment to addressing critical public health issues.

At the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies in 2015, held in Washington DC, Dr. Yen presented a poster on the impact of ART on the incidence of ADC and non-ADC. This contribution showcased his dedication to advancing knowledge in the intersection of HIV/AIDS and cancer.

Yen, along with Yu-Shiuan Lin, presented a poster at the 45th Union World Conference on Lung Health in Barcelona, Spain, in 2014. The study focused on the determinants of death before and during tuberculosis treatment among elderly patients in Taipei, Taiwan, emphasizing his commitment to understanding and improving tuberculosis outcomes

In 2017, at the International Conference on Alcohol and Drugs in Osaka, Japan, Dr. Yen delivered an oral presentation on the association between heavy alcohol consumption and the increased risk of active tuberculosis in Taiwanese adults. This research underscored his dedication to exploring the broader social determinants of infectious diseases.

Recognition and Achievements:

Dr. Yung-Feng Yen's work has garnered attention at various international conferences, reflecting his standing as a respected expert in the field of infectious diseases.

Commitment to Education and Mentorship:

Beyond research and publication,Yung-Feng Yen is dedicated to the education and mentorship of emerging scholars and medical professionals. Their commitment to fostering the next generation of researchers underscores their passion for advancing the field.

Yung-Feng Yen inclusion on the editorial board of "Annals of Thyroid Research & Endocrinology" is a testament to their standing as a respected figure in endocrinology, contributing significantly to the dissemination of knowledge in thyroid research.

NOTABLE PUBLICATIONS

1. Yen YF, Lin YC, Chen TL, Chen YY, Lin ML, Wang FD, Liu CY. Prognostic factors and clinical features of non-typhoid Salmonella bacteremia in adults. J Chin Med Assoc 2009;72(8):408–413 (SCI IF=0.67)

2. Sheng-Fan Wang, Yuan-Ming Lee, Yu-Jiun Chan, Hsin-Fu Liu, Yung-Fong Yen, Wu-Tse Liu, Jason C. Huang, Yi- Ming Chen, Influenza A Virus in Taiwan, 1980-2006: Phylogenetic and Antigenic Characteristics of the Hemagglutinin Gene. Journal of Medical Virology. 81:1457–1470, 2009. (SCI IF=2.9)

3. Kuo HY, Wang FD, Yen YF, Lin ML, Liu CY. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli. New Microbiol. 2009 Jan;32(1):49-55. (SCI IF=0.7)

4. Yen YF, Lin YC, Chen TL, Chen YY, Lin ML, Wang FD, Liu CY. Non-typhoidal Salmonella bacteremia in adults. J Microbiol Immunol Infect. 2007 Jun;40(3):227-33. (SCI IF=1.1)

5. Wang HP, Yen YF, Chen WS, Chou YL, Tsai CY, Chang HN, Chou CT. An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy. Clin Rheumatol. 2007 Jul;26(7):1195-7. (SCI IF=1.7)

6. Yung-Feng Yen, Timothy C. Rodwell, Muh-Yong Yen, Hsiu-Chen Shih, Bor-Shen Hu, Lan-Huei Li, Ying-Huei Shie, Peing Chuang, Richard S. Garfein,. DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006- 2008. International Journal of Tuberculosis and Lung Diseases. 2012; 16(2): 178–184. (SCI IF=2.5)

7. Yen YF, Yen MY, Shih HC, Deng CY. Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan. Trans R Soc Trop Med Hyg. May 2012;106(5):303-308. (SCI IF=1.8)

8. Yen YF, Rodwell TC, Yen MY, Hsu YH, Chuang P, Li LH, Su LW, Yang YH, Jiang XR, Fang YC, Garfein RS. HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007-2010. Am J Drug Alcohol Abuse. 2012 Nov;38(6):544-50 (SCI IF=1.4)

9. Yen YF, Yen MY, Su LW, Li LH, Chuang P, Jiang XR, Deng CY. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan. BMC Public Health. 2012 Dec 11;12:1066. (SCI IF=2.0)

10. Yung-Feng Yen, Bor-Shen Hu, Yu-Shiuan Lin, Lan-Huei Li, Lien-Wen Su, Peing Chuang, Nai-Ching Lin, Xiao-Ru Jiang, Ying-Huei Shie, Hsiao-Hui Chang, Wei-Xian Ou, Hong-Jun Zhan, Winnie Yang, and Muh-Yong Yen. Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus Tuberculin Skin Test. Scand J Infect Dis. 2013 Jul;45(7):504-11. (SCI IF=1.7)

11. Yu-Shiuan Lin, I-Fen Lin, Yung-Feng Yen*, Pei-Ching Lin, Yu-chih Shiu, Hsing-Yi Hu, Ying-Pi Yang. Impact of an antimicrobial stewardship program with multidisciplinary cooperation in a community public teaching hospital of Taiwan. Am J Infect Control. 2013 Jul 16. (SCI IF=2.4)

12. Yung-Feng Yen, Muh-Yong Yen, Hsiu-Chen Shih, Bor-Shen Hu, Bo-Lung Ho, Lan-Huei Li, Jen-Chieh Hsiao, and Chung-Yeh Deng. Prognostic Factors Associated with Mortality before Start of and during Tuberculosis Treatment. Int J Tuberc Lung Dis. 2013 Oct;17(10):1310-6. (SCI IF=2.6)

13. Yung-Feng Yen, Muh-Yong Yen, Yi-Ping Lin, Hsiu-Chen Shih, Lan-Huei Li, Pesus Chou, Chung-Yeh Deng. Directly Observed Therapy Reduces Tuberculosis-Specific Mortality: A Population-Based Follow-Up Study in Taipei, Taiwan. PLoS One 2013, 8(11):e79644. (SCI IF=3.7)

14. Yen, Yung-Feng; Yen, Muh-Yong; Lin, Yu-Shiuan; Lin, Yi-Ping; Shih, Hsiu-Chen; Li, Lan-Huei; Chou, Pesus; Deng, Chung-Yeh.* "Smoking Increases Risk of Recurrence after Successful Tuberculosis Treatment: a Population-Based Study." Int J Tuberc Lung Dis. 2014 Apr;18(4):492-8. (SCI IF=2.6)

15. Yen YF, Yen MY, Lin T, Li LH, Jiang XR, Chou P, Deng CY. Prevalence and factors associated with HIV infection among injection drug users at methadone clinics in Taipei, Taiwan. BMC Public Health. 2014; 14(1):682. (SCI IF 2.0)

16. Yen YF, Chou P, Lin YS, Deng CY. Factors associated with health-related quality of life among injection drug users at methadone clinics in Taipei, Taiwan. J Chin Med Assoc. 2015 May; 78(5):292-8. (SCI IF 0.9)

17. Lin YS, Yen YF*. Determinants of mortality before start of and during tuberculosis treatment among elderly patients: a population-based retrospective cohort study. Age Ageing. 2015 May;44(3):490-6. (SCI IF=3.1)

18. Yen YF, Chung MS, Hu HY, Lai YJ, Huang LY, Lin YS, Chou P, Deng CY. Association of pulmonary tuberculosis and ethambutol with incident depressive disorder: a nationwide, population-based cohort study. J Clin Psychiatry. 2015 Apr;76(4):e505-11.(SCI IF 5.1)

19. Yen YF, Hu HY, Lin IF, Lai YJ, Su VY, Pan SW, Ting WY, Su WJ. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults. Medicine (Baltimore). 2015 Jun;94(23):e956. (SCI IF 5.6)

20. Pan SW#, Yen YF#, Feng JY, Su VY, Kou YR, Su WJ: The Risk of Depressive Disorder Among Contacts of Tuberculosis Patients in a TB-endemic Area: A Population-based Cohort Study. Medicine (Baltimore) 2015, 94(43):e1870. (#Equal contribution) (SCI IF 5.6)

21. Yung-Feng Yen, MD, MPH, PhD, Pei-Hung Chuang, PhD, Muh-Yong Yen, MD, Shu-Yi Lin, MS, Peing Chuang, MS, Mei-Jen Yuan, , MS, Bo-Lung Ho, MD, Pesus Chou, ScD, Chung-Yeh Deng, MD, ScD: Association of Body Mass Index with Tuberculosis Mortality: A Population-based Follow-up Study. Medicine (Baltimore). 2016 Jan;95(1):e2300.

22. Yen YF, Jen I, Chen M, Chuang PH, Liu YL, Sharp GB, Chen YM. Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study. PLoS One. 2016 Mar 17;11(3):e0151684.

23. Su VY, Yen YF#, Pan SW, Chuang PH, Feng JY, Chou KT, Chen YM, Chen TJ, Su WJ. Latent Tuberculosis Infection and the Risk of Subsequent Cancer. Medicine (Baltimore). 2016 Jan;95(4):e2352. (#Equal contribution)

24. Yen YF, Chuang PH, Jen IA, Chen M, Lan YC, Liu YL, Lee Y, Chen YH, Chen YA. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012. Ann Rheum Dis. 2017 Apr;76(4):661-665. (SCI)

25. Yen YF, Chen M, Jen I, Lan YC, Chuang PH, Liu YL, Lee Y, Arthur Chen YM. Association of HIV and Opportunistic Infections with Incident Stroke: A Nationwide Population-based Cohort Study in Taiwan. J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):117-125. (SCI)

26. Lai HH, Lai YJ, Yung-Feng Yen*. Association of Body Mass Index with Timing of Death during Tuberculosis Treatment. PLoS One. 2017 Jan 13;12(1):e0170104. (SCI)

27. Chen YY, Feng JY, Ting WY, Yen YF, Chuang PH, Pan SW, Su VY, Su WJ. Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area. Osteoporos Int. 2017 May;28(5):1711-1721. (SCI)

28. Yen YF, Hu HY, Lee YL, Ku PW, Lin IF, Chu D, Lai YJ. Obesity/overweight reduces the risk of active tuberculosis: a nationwide population-based cohort study in Taiwan. Int J Obes (Lond). 2017 Jun;41(6):971-975. (SCI)

29. Yen YF, Feng JY, Pan SW, Chuang PH, Su VY, Su WJ. Determinants of mortality in elderly patients with tuberculosis: a population-based follow-up study. Epidemiol Infect. 2017 May;145(7):1374-1381. (SCI)

30. Yen YF, Jen IA, Chen M, Lan YC, Lee CY, Chuang PH, Lee Y, Arthur Chen YM. Human Immunodeficiency Virus Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-based Cohort Study in Taiwan. J Acquir Immune Defic Syndr. 2017 Apr 25. (SCI)

31. Yen YF, Hu HY, Lee YL, Ku PW, Chuang PH, Lai YJ, Chu D. Heavy alcohol consumption increases the risk of active tuberculosis in Taiwanese adults: a nation-wide population-based cohort study. Addiction. 2017 Dec;112(12):2124-2131.

32. Lai YJ, Hu HY, Lee YL, Ku PW, Yen YF#, Chu D. A retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan. BMC Cardiovasc Disord. 2017 May 22;17(1):130. (#co-corresponding author)

33. Yung-Feng Yen, Yu-Ching Lan, Chun-Teng Huang, I-An Jen, Marcelo Chen, Chun-Yuan Lee, Pei-Hung Chuang, Yun Lee, Donalde E. Morisky, Yi-Ming Arthur Chen. Human Immunodeficiency Virus Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-based Cohort Study in Taiwan. J Infect Dis. 2017 Nov 15;216(8):1000-1007. (SCI)

34. Yen YF, Tung FI, Ho BL, Lai YJ. Underweight increases the risk of early death in tuberculosis patients. Br J Nutr. 2017 Dec;118(12):1052-1060. (SCI)

35. Lai YJ, Hu HY, Lee YL, Ku PW, Yen YF#, Chu D. Association between obesity and risk of chronic kidney disease: A nationwide Cohort study in Taiwan. Nutr Metab Cardiovasc Dis. 2017 Nov;27(11):1008-1014. (SCI) (#co-corresponding author)

36. Yen YF, Huang LY, Hu HY, Sun WJ, Ko MC, Lee YL, Huang SJ, Chu D. Association of Advance Directives Completion With the Utilization of Life-Sustaining Treatments During the End-of-Life Care in Older Patients. J Pain Symptom Manage. 2018 Feb;55(2):265-271. (SCI)

37. Su VY, Su WJ, Yen YF, Pan SW, Chuang PH, Feng JY, Chou KT, Yang KY, Lee YC, Chen TJ. Statin Use Is Associated With a Lower Risk of TB. Chest. 2017 Sep;152(3):598-606. (SCI)

38. Yen YF, Pan SW, Su VY, Chuang PH, Feng JY, Su WJ. Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1). Emerg Infect Dis. 2018 Mar;24(3):498-505. doi: 10.3201/eid2403.152071. PubMed PMID: 29460733; PubMed Central PMCID: PMC5823323. (SCI)

39. Yen YF, Hu HY, Lee YL, Ku PW, Ko MC, Chuang PH, Lai YJ, Chu D. Sexual inequality in incident tuberculosis: a cohort study in Taiwan. BMJ Open. 2018 Feb 6;8(2):e020142. doi: 10.1136/bmjopen-2017-020142. PubMed PMID: 29437757; PubMed Central PMCID: PMC5829922. (SCI)

40. Su VY, Yang KY, Yang YH, Tsai YH, Perng DW, Su WJ, Chou KT, Su KC, Yen YF, Chen PC. Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma. J Allergy Clin Immunol Pract. 2018 Feb 10. pii: S2213-2198(18)30090-4. doi: 10.1016/j.jaip.2018.01.035. [Epub ahead of print] PubMed PMID: 29432960. (SCI)

41. Pan SW, Yen YF, Kou YR, Chuang PH, Su VY, Feng JY, Chan YJ, Su WJ. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest. 2018 Jun;153(6):1347-1357. (SCI)

42. Yen YF, Jen IA, Chuang PH, Chen M, Lan YC, Lee CY, Arthur Chen YM. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS. Ann Epidemiol. 2018 Mar 28. (SCI)

43. Lee CY, Jen IA, Lan YC, Yen YF, Chuang PH, Chen M, Lee Y, Chen YA. AIDS incidence trends at presentation and during follow-up among HIV-at-risk populations: a 15-year nationwide cohort study in Taiwan. BMC Public Health. 2018 May 3;18(1):589. (SCI)

44. Chu D#, Yen YF#, Hu HY, Lai YJ, Sun WJ, Ko MC, Huang LY, Chen CC, Curtis JR, Lee YL#, Huang SJ. Factors associated with advance directives completion among patients with advance care planning communication in Taipei, Taiwan. PLoS One. 2018 Jul 6;13(7):e0197552. (SCI) (#co-first author)

45. Yung-Feng Yen, Jia-Yih Feng, Vincent Yi-Fong Su, Pei-Hung Chuang, Ming-Chung Ko, Chu-Chieh Chen, Yi-Jie Li, Sheng-Wei Pan, Wei-Juin Su. Human Immunodeficiency Virus Infection Increases the Risk of Incident Uveitis among People Living with HIV/AIDS. J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):149-157. (SCI)

46. Yun-Ju Lai, Yu-Yen Chen, Hsin-Hui Huang, Ming-Chung Ko, Chu-Chieh Chen, Yung-Feng Yen*. Incidence of cardiovascular diseases in a nationwide HIV/AIDS patient cohort in Taiwan from 2000–2014. Epidemiol Infect. 2018 Dec;146(16):2066-2071. (SCI)

47. Lai YJ, Hu HY, Lee YL, Ko MC, Ku PW, Yen YF#, Chu D. Frequency of alcohol consumption and risk of type 2 diabetes mellitus: A nationwide cohort study. Clin Nutr. 2018 Jun 13. (SCI) (#co-corresponding author)

48. Yen YF, Chen M, Jen IA, Chuang PH, Lee CY, Lin SI, Chen YA. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS. Sci Rep. 2019 Mar 5;9(1):3476. (SCI)

49. Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018 Dec;18(12):1397-1409. (SCI)

50. Hu HY, Jian FX, Lai YJ, Yen YF, Huang N, Hwang SJ. Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study. BMJ Open. 2019 Sep 13;9(9):e031354. (SCI)

51. Lai YJ, Chen YY, Lin YK, Chen CC, Yen YF,# Deng CY. Alcohol Consumption and Risk of Chronic Kidney Disease: A Nationwide Observational Cohort Study. Nutrients. 2019 Sep 6;11(9). (#co-corresponding author) (SCI)

52. Pan SW, Yen YF, Feng JY, Chuang PH, Su VY, Kou YR, Su WJ, Chan YJ. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: a population-based cohort study. Br J Clin Pharmacol. 2019 Oct 21. (SCI)

53. Lai YJ, Lai HH, Chen YY, Ko MC, Chen CC, Chuang PH, Yen YF*, Morisky DE. Low socio-economic status associated with increased risk of dengue haemorrhagic fever in Taiwanese patients with dengue fever: a population-based cohort study. Trans R Soc Trop Med Hyg. 2020 Feb 7;114(2):115-120. (SCI)

54. Yen YF, Ko MC, Yen MY, Hu BS, Wang TH, Chuang PH, Lai HH, Chen CC, Deng CY. Human Immunodeficiency Virus Increases the Risk of Incident Heart Failure. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):255-263. (SCI)

55. Yen YF, Lai YJ, Chen YY, Lai HH, Chuang PH, Chen CC, Deng CY. Association of HIV Infection and Antiretroviral Therapy With Sudden Cardiac Death. J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):468-474. (SCI)

56. Yen YF, Lee YL, Hu HY, Lai YJ, Sun WJ, Ko MC, Chen CC, Curtis JR, Huang SJ, Chu D. An Interventional Study for the Early Identification of Patients with Palliative Care Needs and the Promotion of Advance Care Planning and Advance Directives. J Pain Symptom Manage. 2020 May;59(5):974-982. (SCI)

57. Lai YJ, Yen YF#, Chen LJ, Ku PW, Chen CC, Lin YK. Association of exercise with all-cause mortality in older Taipei residents. Age Ageing. 2020 Apr 27;49(3):382-388. (SCI) (#co-first author)

58. Lai YJ, Chen YY, Ko MC, Chou YS, Huang LY, Chen YT, Hung KC, Lin YK, Wang CC, Chen CC, Chuang PH, Yen YF*. Low Socioeconomic Status Associated with Lower Utilization of Hospice Care Services during End-of-life Treatment in Cancer Patients: A Population-based Cohort Study. J Pain Symptom Manage. 2020 Aug;60(2):309-315.

59. Dental care and infection-control procedures during the COVID-19 pandemic: The experience in Taipei City Hospital, Taiwan Ya-Ling Lee, Dachen Chu, Sin-Yi Chou, Hsiao-Yun Hu, Sheng-Jean Huang, Yung-Feng Yen# J Dent Sci. 2020 May 29. (SCI) (#co-corresponding author)

60. Lai HH, Kuo YC, Kuo CJ, Lai YJ, Chen M, Chen YT, Chen CC, Yen MY, Hu BS, Wang TH, Wang CC, Kuo LL, Yen TF, Chuang PH, Yen YF#. Methamphetamine Use Associated with Non-adherence to Antiretroviral Treatment in Men Who Have Sex with Men. Sci Rep. 2020 Apr 28;10(1):7131. (SCI)

61. Pan SW, Yen YF, Feng JY, Chuang PH, Su VY, Kou YR, Su WJ, Chan YJ. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study. Br J Clin Pharmacol. 2020 Mar;86(3):569-579. (SCI)

62. Chou YC, Yen YF#, Feng RC, Wu MP, Lee YL, Chu D, Huang SJ, Curtis JR, Hu HY. Impact of the COVID-19 Pandemic on the Utilization of Hospice Care Services: A Cohort Study in Taiwan. J Pain Symptom Manage. 2020 Sep;60(3):e1-e6. (SCI)

63. Yen YF*, Lai HH, Chan SY, Su VY, Chiu TF, Huang CY, Hung CC, Kuo TL, Lee YL, Chu D. Olfactory disorder in patients infected with SARS-CoV-2. J Microbiol Immunol Infect. 2020 Aug 20:S1684-1182(20)30208-5. (SCI)

64. Yi-Fong Su V, Yen YF, Yang KY, Su WJ, Chou KT, Chen YM, Perng DW. Masks and medical care: Two keys to Taiwan's success in preventing COVID-19 spread. Travel Med Infect Dis. 2020 Jun 4:101780. (SCI)

65. Yen YF*, Lai YJ, Ko MC, Chen YY, Chen YT, Chou YS, Huang CT, Chen CC. Association of Hospice Care Services With the Utilization of Life-Sustaining Treatments During End-of-Life Care Among Patients With Cancer: A Nationwide 11-Year Cohort Study. J Pain Symptom Manage. 2020 Jul 30:S0885-3924(20)30640-0. (SCI)

66. Chen YY, Lai YJ, Yen YF, Huang LY. Use of iStent as a Standalone Operation in Patients with Open-Angle Glaucoma. J Ophthalmol. 2020 May 24. (SCI)

67. Chen YT, Yen YF, Yu SH, Su EC. An Examination on the Transmission of COVID-19 and the Effect of Response Strategies: A Comparative Analysis. Int J Environ Res Public Health. 2020 Aug 6;17(16):E5687. (SCI)

68. Yen YF*, Lee YL, Hu HY, Sun WJ, Ko MC, Chang SS, Chen CC, Huang SJ, Chu D. Association of advance care planning with place of death and utilisation of life-sustaining treatments in deceased patients at Taipei City Hospital in Taiwan. BMJ Support Palliat Care. 2020 Oct 28:bmjspcare-2020-002520. (SCI)

69. Yen YF#, Tsai YF, Su VY, Chan SY, Yu WR, Ho H, Hou CM, Chen CC, Woung LC, Huang SJ. Use and Cost-Effectiveness of a Telehealth Service at a Centralized COVID-19 Quarantine Center in Taiwan: Cohort Study. J Med Internet Res. 2020 Dec 11;22(12):e22703. doi: 10.2196/22703 (#co-corresponding author)

70. Chen YY, Lai YJ, Yen YF, Chen HH, Chou P. Uveitis as a potential predictor of acute myocardial infarction in patients with Behcet's disease: a population-based cohort study. BMJ Open. 2021 Jan 15;11(1):e042201. (SCI)

71. Su VY, Pan SW, Yen YF, Feng JY, Su WJ, Chen YM. Statin use and impact on tuberculosis risk. Expert Rev Anti Infect Ther. 2021 Mar 1:1-6. (SCI)

72. Lee YL, Hu HY, Yen YF, Chu D, Yang NP, Chou SY, Lin SY, Chu CM, Huang SJ. Impact of the COVID-19 pandemic on the utilization of medical and dental services in Taiwan: A cohort study. J Dent Sci. 2021 Feb 17. (SCI)

73. Lin YK, Wang CC, Yen YF, Chen LJ, Ku PW, Chen CC, Lai YJ. Association of body mass index with all-cause mortality in the elderly population of Taiwan: A prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):110-118. (SCI) (co-first author)

74. Yen YF*, Lai YJ, Ko MC, Chen YY, Chen YT, Chou YS, Huang CT, Chen CC. Association of Hospice Care Services With the Utilization of Life-Sustaining Treatments During End-of-Life Care Among Patients With Cancer: A Nationwide 11-Year Cohort Study. J Pain Symptom Manage. 2021 Feb;61(2):323-330. (SCI)

75. Yen MY, Yen YF, Chen SY, Lee TI, Huang GH, Chan TC, Tung TH, Hsu LY, Chiu TY, Hsueh PR, King CC. Learning from the past: Taiwan's responses to COVID-19 versus SARS. Int J Infect Dis. 2021 Jun 4:S1201-9712(21)00490-2. (SCI)

76. Tsai YF, Chen SY, Yen YF, Huang TC. Taiwan can help-Community protection net: preventive effects of the Northern Taiwan Centralized Quarantine Center against SARS-CoV-2. Public Health. 2021 Apr 27:S0033-3506(21)00154-2. (SCI)

77. Yi-Chang Chou, Yung-Feng Yen, Dachen Chu, Hsiao-Yun Hu. Impact of the COVID-19 Pandemic on Healthcare-Seeking Behaviors among Frequent Emergency Department Users: A Cohort Study. Int J Environ Res Public Health. 2021: 18(12), 6351. (co-first author)

78. Chiu TF, Yen MY, Shie YH, Huang HL, Chen CC, Yen YF*. Determinants of latent tuberculosis infection and treatment interruption in long-term care facilities: A retrospective cohort study in Taiwan. J Microbiol Immunol Infect. 2021 Oct 11:S1684-1182(21)00201-2. (SCI)

79. Chou YC, Yen YF#, Feng RC, Wu MP, Lee YL, Chu D, Huang SJ, Curtis JR, Hu HY. Impact of the COVID-19 Pandemic on the Utilization of Hospice Care Services: A Cohort Study in Taiwan. J Pain Symptom Manage. 2020 Sep;60(3):e1-e6. (SCI) (#co-corresponding author)

80. Lai YJ, Chen YY, Ku PW, Chen LJ, Yen YF#. Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus: A 4.5-year cohort study. Medicine (Baltimore). 2021 Oct 15;100(41):e27496. (SCI) (#co-corresponding author)

81. Cheng FS, Yung-Feng Yen, Lin SY, Weng SH, Chou YC, Chu D, Chen CC, Hu HY. Prevalence and Factors Associated with the Reuse of Mask during the COVID-19 Pandemic: A Nationwide Survey in Taiwan. Int J Environ Res Public Health. 2021 Jul 29;18(15):8065. (co-first author) (SCI)

82. Chen YY, Yen YF, Huang LY, Chou P. Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis. J Ophthalmol. 2021 Jun 19;2021:9997631. (SCI)

83. Lai YJ, Ko MC, Chan SY, Chou YS, Wang CC, Ku PW, Chen LJ, Hsu LF, Chuang PH, Chen CC, Yen YF*. Hospice Care Services Associated With a Lower Utilization of Life-Sustaining Treatments During End-Of-Life Care Among People Living With HIV/AIDS: A Population-Based Cohort Study. Am J Hosp Palliat Care. 2022 Jan 19:10499091211072240. (SCI)

84. Chen YY, Lai YJ, Yen YF, Chou P. Increased mortality after intravitreal injections of anti-VEGF for neovascular AMD among patients with prior stroke or acute myocardial infarction. Eye (Lond). 2022 Jan;36(1):153-159. (SCI)

85. Yen YF, Hu HY, Chou YC, Chen CC, Ho CY. Utilization of Palliative Care Screening Tool to Early Identify Patients with COVID-19 Needing Palliative Care: A Cohort Study. Int J Environ Res Public Health. 2022 Jan 18;19(3):1054. (SCI)

86. Chen WR, Kong PH, Sauer C, Chen HW, Chan HY, Yang DP, Jair YC, Liu HT, Lin TY, Yen MY, Yen YF, Chang SH, Li LH, George C, Chang YC, Wu YH, Hwa HL, Chen CY, Chen JH, Kicman AT, Maurer HH, Chen PS. A proposed approach to confirm heroin administration - Regional differences in heroin purity is a major factor. Regul Toxicol Pharmacol. 2022 Feb;128:105097. (SCI)

87. Yen YF, Lai HH, Kuo YC, Chan SY, Chen LY, Chen CC, Wang TH, Wang CC, Chen M, Yen TF, Kuo LL, Kuo ST, Chuang PH. Association of depression and antidepressant therapy with antiretroviral therapy adherence and health-related quality of life in men who have sex with men. PLoS One. 2022 Feb 25;17(2):e0264503. (SCI)

88. Chan SY, Lai YJ, Ko MC, Chen YY, Tsai YF, Hsu LF, Ku PW, Chen LJ, Chuang PH, Chen CC, Yen YF*. Is there lower utilisation of hospice care services during end-of-life care for people living with HIV? A population-based cohort study. BMJOpen. 2022 Mar 14;12(3):e058231. (SCI)

89. Yen YF, Hu HY, Lai YJ, Chou YC, Chen CC, Ho CY. Comparison of intuitive assessment and palliative care screening tool in the early identification of patients needing palliative care. Sci Rep. 2022 Mar 23;12(1):4955. (SCI)

90. Yen YF, Hu HY, Chen CC, Chu D, Lee YL. Clinical sensitivity of rapid antigen test during a COVID-19 outbreak in Taipei, May to June 2021. J Formos Med Assoc. 2022 Mar 28:S0929-6646(22)00138-3. (SCI)

91. Chan SY, Lai YJ, Chen YY, Chiang SJ, Tsai YF, Hsu LF, Chuang PH, Chen CC, Yen YF*. End-of-life discussions reduce the utilization of life-sustaining treatments during the last three months of life in cancer patients. Sci Rep. 2022 May 6;12(1):7477. (SCI)

92. Yen YF, Chan SY, Chen CC, Deng CY. Predictors for Early and Late Death in Adult Patients with COVID-19: A Cohort Study. Int J Environ Res Public Health. 2022 Mar 12;19(6):3357.

93. Yen YF*, Lee YL, Hu HY, Sun WJ, Ko MC, Chen CC, Wong WK, Morisky DE, Huang SJ, Chu D. Early palliative care: the surprise question and the palliative care screening tool-better together. BMJ Support Palliat Care. 2022 Jun;12(2):211-217. (SCI)

94. Chen YY, Lai YJ, Yen YF, Chou P. Increased mortality after intravitreal injections of anti-VEGF for neovascular AMD among patients with prior stroke or acute myocardial infarction. Eye (Lond). 2022 Jan;36(1):153-159. (SCI)

95. Yen YF, Wang CC, Chen YY, Hsu LF, Hung KC, Chen LJ, Ku PW, Chen CC, Lai YJ. Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study. Diabetes Metab. 2022 Jul 21;48(6):101378. (SCI)

96. Chan SY, Tsai YF, Yen MY, Yu WR, Hung CC, Kuo TL, Chen CC, Yen YF*, Huang SH, Huang TC, Huang SJ. Out-of-hospital cardiac arrest and in-hospital mortality among COVID-19 patients: a population-based retrospective cohort study. J Microbiol Immunol Infect. 2022 Aug. (SCI)

97. Lai YJ, Yen YF*, Chen LJ, Hsu LF, Ahmadi MN, Inan-Eroglu E, Ku PW, Stamatakis E: Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan. Diabetes & Metabolism 2022. (SCI)

Most Reader’s Article Award

Published on 18/11/202318/11/2023 by Oncology

Introduction: Welcome to the pinnacle of reader appreciation—the 'Most Reader's Article Award.' This distinguished honor celebrates writers whose articles have resonated deeply with readers, making a lasting impact and leaving an indelible mark.

Award Overview: The 'Most Reader's Article Award' recognizes outstanding individuals who have crafted articles that captivate and engage readers across diverse audiences.

Eligibility:

Open to writers and authors of all ages
Articles must be published and have demonstrated significant readership
No specific qualifications required, celebrating the power of impactful storytelling
Open to a wide range of genres and topics

Evaluation Criteria: Candidates will be evaluated based on the depth of engagement their articles generate, the impact on readers, and the ability to connect with a broad audience.

Submission Guidelines:

Submit a biography highlighting writing experience and achievements.
Provide an abstract summarizing the impact of the submitted article.
Include the article along with supporting files that showcase its reader engagement.

Recognition: The recipient will receive widespread recognition for crafting an article that resonates with readers, fostering a sense of connection and community through the power of words.

Community Impact: Emphasis will be placed on the nominee's influence on the literary community, fostering a culture of thoughtful and impactful storytelling.